Analyst Reco. Edwards Lifesciences Corporation Swiss Exchange

Equities

EW

US28176E1082

Market Closed - Swiss Exchange Other stock markets 09:05:35 27/06/2019 pm IST			5-day change	1st Jan Change
60.6 ^CHF	-1.45%		-.--%	-.--%

20/06	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT
17/06	Edwards Lifesciences Corporation Announces Executive Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	21/06	MT
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	17/06	MT
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	22/05	MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	14/05	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	14/05	MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	07/05	MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	02/05	MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	01/05	MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72	29/04	MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92	26/04	MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83	26/04	MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94	26/04	MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating	26/04	MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85	26/04	MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86	26/04	MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100	17/04	MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating	17/04	MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca	16/04
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97	15/04	MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept	15/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 08:55 pm IST